Nano-Ciprofloxacin/Meropenem Exhibit Bactericidal Activity Against Gram-Negative Bacteria and Rescue Septic Rat Model
- 1 September 2023
- journal article
- research article
- Published by Taylor & Francis in Nanomedicine
- Vol. 18 (22) , 1553-1566
Abstract
Aim: We hypothesized that simultaneous administration of two antibiotics loaded into a nanopolymer matrix would augment their synergistic bactericidal interaction. Methods: Nanoplatforms of chitosa... Plain language summary Antibiotics are used to treat bacterial infections. However, the more they are used, the less effective they become, because bacteria develop resistance to them. One strategy... Tweetable abstract CS/Plu-Cip/Mer resulting in a bactericidal effect versus the Cip/Mer bacteriostatic effect. The CS/Plu-Cip/Mer resulted in statistically significant reductions in all measures te... Graphical abstract Nano-Cip/Mer enhanced the survival rate and decreased the bacterial load in a septic rat model.Keywords
Funding Information
- Science and Technology Development Fund (25913)
This publication has 50 references indexed in Scilit:
- Combination Therapy for Treatment of Infections with Gram-Negative BacteriaClinical Microbiology Reviews, 2012
- Electrostatic Interactions Affect Nanoparticle-Mediated Toxicity to Gram-Negative Bacterium Pseudomonas aeruginosa PAO1Langmuir, 2009
- Formulation and Characterization of Echogenic Lipid−Pluronic NanobubblesMolecular Pharmaceutics, 2009
- Efficacy of the Combination of Tachyplesin III and Clarithromycin in Rat Models of Escherichia coli SepsisAntimicrobial Agents and Chemotherapy, 2008
- LL-37 Protects Rats against Lethal Sepsis Caused by Gram-Negative BacteriaAntimicrobial Agents and Chemotherapy, 2006
- In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysisJournal of Antimicrobial Chemotherapy, 2006
- Activity of Levofloxacin and Ciprofloxacin in Combination with Cefepime, Ceftazidime, Imipenem, Piperacillin-Tazobactam and Amikacin against Different Pseudomonas aeruginosa Phenotypes and Acinetobacter spp.Chemotherapy, 2004
- The mutant selection window and antimicrobial resistanceJournal of Antimicrobial Chemotherapy, 2003
- In vitro activity of β-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosaInternational Journal of Antimicrobial Agents, 2003
- N-carboxymethylchitosan inhibition of aflatoxin production: Role of zincBiotechnology Letters, 1991